Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1986 Jun;76(6):647–656. doi: 10.2105/ajph.76.6.647

Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.

G Oster, A M Epstein
PMCID: PMC1646773  PMID: 3486601

Abstract

We examined the expected economic benefits of cholesterol lowering for adult men with significant elevations of total serum cholesterol (above 260 mg/dl), incorporating estimates of direct benefits from anticipated reductions in lifetime expenditures for medical care, and estimates of indirect benefits related to extension of work-life secondary to reductions in morbidity and premature mortality. Our findings yield discounted lifetime direct benefits of a 15 per cent reduction in total serum cholesterol of $3 to $208 per person, and discounted lifetime indirect benefits of $1 to $8,946. Benefits increase with an individual's initial cholesterol level and decrease with the age at which an intervention is initiated. Economic benefits increase approximately twofold in the presence of other coronary risk factors, such as cigarette smoking and hypertension. Results suggest that cholesterol-lowering interventions, no matter what their cost, are unlikely to result in substantial direct savings to the health care system. However, the indirect benefits of intervention are quite high for young and middle-aged adults, as well as for those with severe elevations of cholesterol or with additional coronary risk factors.

Full text

PDF
647

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avorn J. Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. N Engl J Med. 1984 May 17;310(20):1294–1301. doi: 10.1056/NEJM198405173102005. [DOI] [PubMed] [Google Scholar]
  2. Dannel W. B. The role of cholesterol in coronary atherogenesis. Med Clin North Am. 1974 Mar;58(2):363–379. [PubMed] [Google Scholar]
  3. Friedewald W. T., Halperin M. Clofibrate in ischemic heart disease. Ann Intern Med. 1972 May;76(5):821–823. doi: 10.7326/0003-4819-76-5-821. [DOI] [PubMed] [Google Scholar]
  4. Kannel W. B., McNamara P. M., Feinleib M., Dawber T. R. The unrecognized myocardial infarction. Fourteen-year follow-up experience in the Framingham study. Geriatrics. 1970 Jan;25(1):75–87. [PubMed] [Google Scholar]
  5. Kannel W. B., Sorlie P., McNamara P. M. Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol. 1979 Jul;44(1):53–59. doi: 10.1016/0002-9149(79)90250-9. [DOI] [PubMed] [Google Scholar]
  6. Kennedy R. H., Kennedy M. A., Frye R. L., Giuliani E. R., McGoon D. C., Pluth J. R., Smith H. C., Ritter D. G., Nobrega F. T., Kurland L. T. Cardiac-catheterization and cardiac-surgical facilities: use, trends, and future requirements. N Engl J Med. 1982 Oct 14;307(16):986–993. doi: 10.1056/NEJM198210143071605. [DOI] [PubMed] [Google Scholar]
  7. Kirchner M. Fee increases: restraint takes over. Med Econ. 1982 Oct 11;59(20):218-27, 231-6, 239-45 passim. [PubMed] [Google Scholar]
  8. Kirchner M. Fees: where they stand in 11 specialties. Med Econ. 1980 Oct 13;57(21):206-14, 217-20, 222-3. [PubMed] [Google Scholar]
  9. Kuller L., Lilienfeld A., Fisher R. Epidemiological study of sudden and unexpected deaths due to arteriosclerotic heart disease. Circulation. 1966 Dec;34(6):1056–1068. doi: 10.1161/01.cir.34.6.1056. [DOI] [PubMed] [Google Scholar]
  10. Levy R. I. The decline in cardiovascular disease mortality. Annu Rev Public Health. 1981;2:49–70. doi: 10.1146/annurev.pu.02.050181.000405. [DOI] [PubMed] [Google Scholar]
  11. Smits H. L., Watson R. E. DRGs and the future of surgical practice. N Engl J Med. 1984 Dec 20;311(25):1612–1615. doi: 10.1056/NEJM198412203112505. [DOI] [PubMed] [Google Scholar]
  12. Stamler J. George Lyman Duff Memorial Lecture. Lifestyles, major risk factors, proof and public policy. Circulation. 1978 Jul;58(1):3–19. doi: 10.1161/01.cir.58.1.3. [DOI] [PubMed] [Google Scholar]
  13. WINSLOW C. E. A. Poverty and disease. Am J Public Health Nations Health. 1948 Jan;38(1 Pt 2):173–184. doi: 10.2105/ajph.38.1_pt_2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wennberg J. E., McPherson K., Caper P. Will payment based on diagnosis-related groups control hospital costs? N Engl J Med. 1984 Aug 2;311(5):295–300. doi: 10.1056/NEJM198408023110505. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES